Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin
- PMID: 1415368
- DOI: 10.1159/000168420
Pain at the injection site of subcutaneously administered erythropoietin in maintenance hemodialysis patients: a comparison of two brands of erythropoietin
Abstract
Local pain due to subcutaneous erythropoietin (EPO) injection into the thigh was studied using a verbal score ranging from 0 to 4. Equivoluminous doses of epoetin-alpha (Cilag) and epoetin-beta (Boehringer) were compared in 2 controlled single-blind experiments: 10 dialysis patients were treated at random for 4 weeks at consecutive sessions with both brands of EPO, and 40 patients were treated in 1 session only with the 2 brands simultaneously. Pain scores were 1.12 +/- 0.28 versus 0.15 +/- 0.06 (p less than 0.05) and 1.75 +/- 0.19 versus 0.08 +/- 0.04 for epoetin-alpha and epoetin-beta, respectively (p less than 0.001). Treatment acceptance was 48% for epoetin-alpha versus 83% for epoetin-beta (p less than 0.05).
Similar articles
-
Pain at the injection site of subcutaneously administered erythropoietin: phosphate-buffered epoetin alpha compared to citrate-buffered epoetin alpha and epoetin beta.Clin Nephrol. 1998 Jan;49(1):41-4. Clin Nephrol. 1998. PMID: 9491285 Clinical Trial.
-
Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study.Clin Nephrol. 1991 Dec;36(6):294-8. Clin Nephrol. 1991. PMID: 1769141 Clinical Trial.
-
Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta.Curr Med Res Opin. 2012 Jul;28(7):1101-10. doi: 10.1185/03007995.2012.688736. Epub 2012 May 23. Curr Med Res Opin. 2012. PMID: 22533679 Clinical Trial.
-
Erythropoietin therapy in patients with chronic renal failure.West J Med. 1992 Aug;157(2):154-7. West J Med. 1992. PMID: 1441466 Free PMC article. Review.
-
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.Transplant Proc. 1991 Apr;23(2):1831-2. Transplant Proc. 1991. PMID: 2053169 Review. No abstract available.
Cited by
-
Epoetin Beta: a review of its clinical use in the treatment of anaemia in patients with cancer.Drugs. 2004;64(3):323-46. doi: 10.2165/00003495-200464030-00006. Drugs. 2004. PMID: 14871172 Review.
-
Effect of lidocaine on the hematopoietic properties of recombinant human erythropoietin in the uremic rat.Pediatr Nephrol. 1994 Aug;8(4):477-9. doi: 10.1007/BF00856536. Pediatr Nephrol. 1994. PMID: 7947041
-
Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.Am J Nephrol. 2018;48(4):251-259. doi: 10.1159/000493097. Epub 2018 Sep 25. Am J Nephrol. 2018. PMID: 30253403 Free PMC article. Clinical Trial.
-
Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.Drugs. 1995 Feb;49(2):232-54. doi: 10.2165/00003495-199549020-00008. Drugs. 1995. PMID: 7729331 Review.
-
Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007. Drugs Aging. 1995. PMID: 7579784 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials